Dr Nimer has been studying the transcriptional regulation of normal and malignant hematopoiesis for decades, with the aim of understanding how the normal processes of stem cell self-renewal and differentiation are regulated and how these processes are aberrant in the myeloid malignancies. Overall, his lab has focused on defining genes that contribute to the development and progression of myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) and on identifying novel ways to target hematologic cancers and make them more responsive to treatment. As a physician-scientist, Dr Nimer has cared for patients with MDS, AML, multiple myeloma, and lymphoma for over three decades.
Primary Specialty
Hematologist
GenderMale
EducationUniversity of Chicago Pritzer School of Medicine
CertificationInternal Medicine, Internal Medicine, Internal Medicine, Internal Medicine